Transarterial chemoembolisation is highly efficacious in patients with hepatocellular carcinoma unsuitable for surgical therapy

Transarterial Chemoembolisation (TACE) is an effective treatment option for patients with unresectable hepatocellular carcinoma (HCC) as proven in a recent meta-analysis. The aim of our study was to evaluate the efficacy of TACE in the patients with HCC not suitable for surgical therapy and in particular to analyze factors affecting survival. In total, 313 patients with unresectable HCC underwent TACE at our institution. The mean age was 63.7 years (17% female, 83% male). The diagnosis was made according to the current AASLD guidelines. The major underlying liver diseases were viral cirrhosis (44%) and alcoholic…